Cargando…
Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence—I
Autores principales: | Wei, Dongqing, Peslherbe, Gilles H., Selvaraj, Gurudeeban, Wang, Yanjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775020/ https://www.ncbi.nlm.nih.gov/pubmed/36551273 http://dx.doi.org/10.3390/biom12121846 |
Ejemplares similares
-
Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021) -
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
por: Kaliamurthi, Satyavani, et al.
Publicado: (2021) -
Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021) -
Artificial Intelligence for Personalized Genetics and New Drug Development: Benefits and Cautions
por: Gallo, Crescenzio
Publicado: (2023) -
Artificial intelligence: more human with human
por: Sipper, Moshe, et al.
Publicado: (2017)